All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BXOS110Phase 31 trial

    Biocells (Beijing) Biotech Co.,Ltd · AIS

  • C2402Not ApplicablePhase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C2403Phase 31 trial

    JW Pharmaceutical · Hypertension, Dyslipidemia

  • C2407Phase 31 trial

    JW Pharmaceutical · Dyslipidemia

  • C52R1LPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • C52R1MPhase 31 trial

    AJU Pharm Co., Ltd. · Essential Hypertension

  • CAM-101Elate Ocular, FD hPLPhase 31 trial

    Cambium Bio Limited · Dry Eye Disease, Dry Eye, Dry Eyes Chronic

  • Jiangsu HengRui Medicine Co., Ltd. · Cervical Cancer

  • cannabidiol as a clear that can be applied to the skinZYN002, transdermal deliveryPhase 31 trial

    Harmony Biosciences Management, Inc. · Fragile X Syndrome, Fragile X Syndrome (FXS)

  • CBT-001Phase 31 trial

    Cloudbreak Therapeutics, LLC · Pterygium

  • celiprololACER-002Phase 31 trial

    Acer Therapeutics Inc. · Vascular Ehlers-Danlos Syndrome

  • cendakimabCC-93538, BMS-986355Phase 31 trial

    Bristol Myers Squibb · Eosinophilic Esophagitis

  • CHF10196florensocatibPhase 31 trial

    Chiesi Farmaceutici S.p.A. · Bronchiectasis

  • CLS2901Chuman [allogeneic] chondrocyte sheetsPhase 31 trial

    CellSeed Inc. · Osteoarthritis of the Knee

  • CMAB015Phase 31 trial

    Taizhou Mabtech Pharmaceutical Co.,Ltd · Psoriasis

  • COYA 302Phase 31 trial

    Coya Therapeutics · Amyotrophic Lateral Sclerosis (ALS)

  • CS-001Phase 31 trial

    Applied Biology, Inc. · Canities, Grey Hair

  • CT001Phase 31 trial

    Cessatech A/S · Pain

  • CTO0308Phase 31 trial

    Taejoon Pharmaceutical Co., Ltd. · Myopia

  • CTP-543Phase 31 trial

    Sun Pharmaceutical Industries, Inc. · Alopecia Areata

  • D07001-SoftgelPhase 31 trial

    InnoPharmax Inc. · Biliary Tract Cancer (BTC)

  • DA-001Phase 31 trial

    Applied Biology, Inc. · Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia

  • DA-007Phase 31 trial

    Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects

  • DA-5219Phase 31 trial

    Dong-A ST Co., Ltd. · Gastritis Acute, Gastritis Chronic

  • DA5221-B1Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-B2Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-T1Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • DA5221-T2Phase 31 trial

    Dong-A ST Co., Ltd. · Type 2 Diabetes

  • dabocemagene autoficelFCX-007, see below for FCX-007 descriptionPhase 31 trial

    Castle Creek Biosciences, LLC. · Recessive Dystrophic Epidermolysis Bullosa

  • DalpciclibPhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Breast Cancer

  • DalpiciclibPhase 31 trial

    Risen (Suzhou) Pharma Tech Co., Ltd. · Breast Cancer

  • DAS181Phase 31 trial

    Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised

  • Debio 4126Phase 31 trial

    Debiopharm International SA · Acromegaly

  • Debio 4326Phase 31 trial

    Debiopharm International SA · Central Precocious Puberty

  • Decartes-08Phase 31 trial

    Cartesian Therapeutics · Myasthaenia Gravis

  • DEH113Phase 31 trial

    EMS · Primary Dysmenorrhea

  • DenifanstatPhase 31 trial

    Sagimet Biosciences Inc. · Acne Vulgaris

  • DeutenzalutamidePhase 31 trial

    AstraZeneca · Metastatic Castration-resistant Prostate Cancer

  • DIT112Phase 31 trial

    EMS · Moderate Pain, Severe Pain

  • DLBS1442DismenoPhase 31 trial

    Dexa Medica Group · Primary Dysmenorrhea

  • DLBS2411RedacidPhase 31 trial

    Dexa Medica Group · Functional Dyspepsia

  • DLBS3233InlacinPhase 31 trial

    Dexa Medica Group · Prediabetes

  • DMT310Phase 31 trial

    Dermata Therapeutics · Acne Vulgaris

  • DMX-200RepagermaniumPhase 31 trial

    Dimerix Bioscience Pty Ltd · FSGS

  • DTT106Phase 31 trial

    EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction

  • DuanorubicinPhase 31 trial

    Arog Pharmaceuticals, Inc. · Newly Diagnosed FLT3 Mutated AML

  • DW4421Phase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Erosive Reflux Disease, GERD (Gastroesophageal Reflux Disease)

  • DW5121Phase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis

  • DW51211Phase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis

  • DW51212Phase 31 trial

    Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis

NewerPage 22 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.